Dr Elizabeth Bird-Lieberman : Gastroenterology

Home
Dr Elizabeth Bird-Lieberman

Fee assured
Verified account
Not in Open Referral network

Overview

Specialises in

Endoscopy

Offers

Face-to-face consultations
Video and telephone consultations

About me

Dr Elizabeth Bird-Lieberman (MB BChir, PhD Cantab, FRCP) is a Consultant Gastroenterologist at the Oxford University Hospitals NHS Trust and, The Manor Hospital, Oxford. In addition to working in general gastroenterology she has a specialist interest in early detection and prevention of cancer within the gastrointestinal tract. Within this role she is a clinical specialist in advanced diagnostic and therapeutic endoscopy and is a nationally accredited Bowel Cancer Screener.

Dr Bird-Lieberman graduated from the University of Cambridge in 2000. Alongside her training in General Internal Medicine and Gastroenterology she achieved a PhD from the University of Cambridge (2010) and following completion of specialist training was appointed a Clinical Lecturer in Translational Medicine and Therapeutics in Cambridge before taking up a consultant post at Oxford University Hospitals in 2013. Her academic interest is in the early detection of gastrointestinal cancers and is an honorary Senior Clinical Lecturer at the University of Oxford. Her PhD thesis focused on the early detection of oesophageal cancer through molecular imaging and biomarker development and she continues to work on early cancer detection throughout the gastrointestinal tract. Her research has been funded by the Medical Research Council, Cancer Research UK, Academy of Medical Sciences, Wellcome Trust and National Institute for Health Research and she has published high impact original research.

Dr Bird-Lieberman has additional roles as editor and reviewer for academic journals and is the Deputy Guidelines Lead for the British Society of Gastroenterology and member of the Gastroenterology Clinical Standards and Services Committee. She is heavily involved in teaching gastroenterology to medical students and the teaching of endoscopy to the next generation of endoscopy specialists and is Academic Foundation Lead for the Oxford University Clinical Academic Graduate School.

Dr Bird-Lieberman is renowned for being an empathic and strong communicator who focuses on providing the best possible care to her patients.

Areas of interest

endoscopy; gastroscopy; colonoscopy; iron deficiency anaemia; dyspepsia; reflux; Helicobacter pylori; Barrett's oesophagus; bowel cancer screening; surveillance; polyps; diarrhoea; constipation; abdominal pain; family risk of gastrointestinal cancer.

Medical secretaries

Karen Arevalo
Nuffield Health The Manor Hospital Beech Road Headington Oxford OX3 7RP
07756 859468
karen.arevalo@nuffieldhealth.com

About me

Current NHS consultant posts held

Consultant Gastroenterologist
John Radcliffe Hospital
Oxford University Hospitals NHS Foundation Trust

Research interests

Dr Bird-Lieberman's academic interest is in the early detection of gastrointestinal cancers and is an honorary Senior Clinical Lecturer at the University of Oxford. Her PhD thesis (University of Cambridge) focused on the early detection of oesophageal cancer through molecular imaging and biomarker development and she continues to work on early cancer detection throughout the gastrointestinal tract. Her research has been funded by the Medical Research Council, Cancer Research UK, Academy of Medical Sciences, Wellcome Trust and National Institute for Health Research and she has published high impact original research.

Personal interests

Dr Bird-Lieberman has additional roles as editor and reviewer for academic journals. She is the Deputy Guidelines Lead for the British Society of Gastroenterolohy and member of the Gastroenterology Clinical Standards and Services Committee. She is heavily involved in teaching gastroenterology to medical students and the teaching of endoscopy to the next generation of endoscopy specialists. She is Academic Foundation Lead for the Oxford University Clinical Academic Graduate School.

Awards received

Fellow of the Royal College of Physicians (2017), Honorary Senior Clinical Lecturer University of Oxford (2017), Joint Advisory Group Nationally recognised Bowel Cancer screener (2014), Honorary Clinical Associate Queen Mary's Hospital Hong Kong (2006).

Dr Bird-Lieberman has received extensive academic funding from prestigious funding bodies including Cancer Research UK, The Medical Research Council, National Institute of Health Research and Academy of Medical Sciences.

Publications

1) Molecular imaging using fluorescent lectins permits rapid endoscopic identification of dysplasia in Barrett's esophagus. Bird-Lieberman EL et al. Nature Medicine 2012; 15;18(2):315-21.
2) Population-Based Study Reveals New Risk-Stratification Biomarker Panel for Barrett's Esophagus. Bird-Lieberman EL, et al. Gastroenterology 2012; 143(4): 927-935.
3) Randomized crossover study comparing efficacy of transnasal endoscopy with that of standard endoscopy to detect Barrett's esophagus. Bird-Lieberman EL, et al. 2012; 75(5):954-61.
4) British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Fitzgerald RC..., Bird-Lieberman EL, et al. Gut 2014; 63(1): 7-42.
5) Electronic imaging to enhance lesion detection at colonoscopy. Ket SN, Bird-Lieberman et al. Gastrointest Endosc Clin N Am. 2015:227-42.
6) Autofluorescence-Directed Confocal Endomicroscopy in Combination With a Three-Biomarker Panel Can Inform Management Decisions in Barrett's Esophagus. di Pietro M, Bird-Lieberman EL, et al. Am J Gastroenterol. 2015 Sep 29. doi: 10.1038/ajg.2015.295.
7) MMP2 and MMP7 at the invasive front of gastric cancer are not associated with mTOR expression. Bornschein J, Seidel T, Langner C, Link A, Wex T, Selgrad M, Jechorek D, Meyer F, Bird-Lieberman E, Vieth M, Malfertheiner P. Diagn Pathol. 2015 Dec 12; 10:212.
8) Diminutive polyps and future colorectal cancer risk perception: how low do we need to go? Bird-Lieberman E and East JE. Endoscopy. 2018 Mar;50(3):197-199.
9) The Rationale and Efficacy of Primary and Secondary Prevention in Adenocarcinomas of the Upper Gastrointestinal Tract. Bornschein J, Bird-Lieberman EL, Malfertheiner P. Dig Dis. 2019;37(5):381-393.
10) Blue Light Imaging and Linked Color Imaging for the Characterization of Mucosal Changes in Chronic Gastritis: A Clinicians View and Brief Technical Report. Weigt J, ... Bird-Lieberman E, et al.. Dig Dis. 2019 Jul 23:1-6.

Courses offered to GPs

1) Evidence basis for the management of Barrett's oesophagus.
2) Helicobacter
3) Endoscopic screening and surveillance for GI cancer
4) Bile acid reflux

My qualifications & training

Qualifications

BA Hons (First) University of Cambridge 1998
PhD University of Cambridge 2011
MB BChir University of Cambridge 2000
FRCP Royal College of Physicians 2017

GMC registration

Reference number 4764984

Professional bodies (positions held - last 3 yrs)

Nationally Accredited Bowel Cancer Screener Joint Advisory Group 2015
Clinical Standards and Services Committee member British Society of Gastroenterology 2019
Honorary Senior Clinical Lecturer University of Oxford 2017

My private practice

Practice hours

Practice
Day
Hours
Appt Bookings

Beech RoadHeadingtonOXFORDOX3 7RP
Monday
12:00 - 17:30
07756 859468

Beech RoadHeadingtonOXFORDOX3 7RP
Tuesday
13:30 - 17:00
07756 859468

Post treatment communication

Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.

In the event of an urgent query following treatment, Bupa members should use the following contact details

07756 859468

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

X3510
IV sedation administered by operator - (5-50)

Nuffield Health The Manor Hospital (5-50)
G6500
Diagnostic oesophago-gastro-duodenoscopy (OGD) includes forceps biopsy, biopsy urease test and dye spray - (5-50)

Nuffield Health The Manor Hospital (5-50)
G8082
Diagnostic oesophago-gastro-duodenoscopy (OGD) and immediate colonoscopy includes forceps biopsies, biopsy test and dye spray (as sole procedure) - (1-5)

Nuffield Health The Manor Hospital (1-5)
H2003
Therapeutic colonoscopy with snare loop biopsy or excision of lesion - (1-5)

Nuffield Health The Manor Hospital (1-5)
G8083
Therapeutic oesophago-gastro-duodenoscopy (OGD) and immediate colonoscopy includes forceps biopsies, biopsy test and dye spray (as sole procedure) - (1-5)

Nuffield Health The Manor Hospital (1-5)
H2002
Diagnostic colonoscopy, includes forceps biopsy of colon and ileum - (1-5)

Nuffield Health The Manor Hospital (1-5)
G8084
Diagnostic oesophago-gastro-duodenoscopy (OGD) and immediate flexible sigmoidoscopy includes forceps biopsies, biopsy test and dye spray (as sole procedure) - (1-5)

Nuffield Health The Manor Hospital (1-5)
Show All (7 )...

Report this page Print page

Finder

Note: